Drugs for parkinsonism.
D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use
D004338:Drug Combinations; D010276:Parasympatholytics; C009265:carbidopa, levodopa drug combination; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine; D002230:Carbidopa